Plain-English translation of NCT05986968 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a sudden heart attack treated with emergency surgery, most patients take two blood-thinning medications together— and —to prevent another attack. This trial is testing whether alone might work just as well while potentially causing less internal bleeding. Researchers will compare patients who take only for 12 months to those who take both medications together, and they'll use heart imaging to measure any bleeding damage inside the heart muscle.
Two blood thinners work better than one at preventing future heart attacks, but they also increase the risk of dangerous bleeding. This trial is trying to find out whether this medication alone can offer the same protection with fewer bleeding problems—which would mean simpler, safer treatment for heart attack survivors.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either one blood-thinning medication () or two medications ( plus ) for 12 months. During the first week after your heart surgery, you'll have a special heart imaging scan (MRI) to measure any internal bleeding. You'll have follow-up visits at 3 months and 13 months to check for any complications, bleeding problems, or new heart events. The study involves about 200 patients at a medical center in the Netherlands.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
Netherlands